IL43770A - Imidazo] a - 2, 1 [Imidazoles, Imidazo] a - 2, 1 [pyramidines, and pyrimido] a - 2, 1 [pyramidines, their preparation and pharmaceutical preparations containing them - Google Patents

Imidazo] a - 2, 1 [Imidazoles, Imidazo] a - 2, 1 [pyramidines, and pyrimido] a - 2, 1 [pyramidines, their preparation and pharmaceutical preparations containing them

Info

Publication number
IL43770A
IL43770A IL43770A IL4377073A IL43770A IL 43770 A IL43770 A IL 43770A IL 43770 A IL43770 A IL 43770A IL 4377073 A IL4377073 A IL 4377073A IL 43770 A IL43770 A IL 43770A
Authority
IL
Israel
Prior art keywords
formula
compound
preparing
process according
tetrahydro
Prior art date
Application number
IL43770A
Other languages
English (en)
Hebrew (he)
Other versions
IL43770A0 (en
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL43770A0 publication Critical patent/IL43770A0/xx
Publication of IL43770A publication Critical patent/IL43770A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/12—Nitrogen atoms not forming part of a nitro radical
    • C07D239/14—Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL43770A 1972-12-08 1973-12-07 Imidazo] a - 2, 1 [Imidazoles, Imidazo] a - 2, 1 [pyramidines, and pyrimido] a - 2, 1 [pyramidines, their preparation and pharmaceutical preparations containing them IL43770A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US313285A US3865836A (en) 1972-12-08 1972-12-08 Bicyclic imidazoles

Publications (2)

Publication Number Publication Date
IL43770A0 IL43770A0 (en) 1974-03-14
IL43770A true IL43770A (en) 1976-08-31

Family

ID=23215116

Family Applications (1)

Application Number Title Priority Date Filing Date
IL43770A IL43770A (en) 1972-12-08 1973-12-07 Imidazo] a - 2, 1 [Imidazoles, Imidazo] a - 2, 1 [pyramidines, and pyrimido] a - 2, 1 [pyramidines, their preparation and pharmaceutical preparations containing them

Country Status (23)

Country Link
US (1) US3865836A (fr)
JP (1) JPS4994694A (fr)
AT (1) AT333770B (fr)
BE (1) BE808416A (fr)
BG (1) BG21608A3 (fr)
CA (1) CA1010864A (fr)
CH (1) CH593975A5 (fr)
DE (1) DE2361188A1 (fr)
DK (1) DK141289B (fr)
FI (1) FI54711C (fr)
FR (1) FR2209576B1 (fr)
GB (1) GB1446482A (fr)
HU (1) HU168638B (fr)
IE (1) IE38618B1 (fr)
IL (1) IL43770A (fr)
NL (1) NL7316778A (fr)
NO (1) NO139087C (fr)
PH (1) PH10417A (fr)
PL (1) PL94683B1 (fr)
RO (1) RO63263A (fr)
SE (1) SE411627B (fr)
SU (1) SU578003A3 (fr)
ZA (1) ZA739343B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU181927B (en) * 1977-07-06 1983-11-28 Iso Pharmachim Process for producing r,s-2,3,5,6-tetrahydro-6-phenyl-imidazo-bracket-2,1-b-bracket closed thiazol /tetramizol/
BG25138A1 (en) * 1977-07-06 1978-08-10 Georgiev A method of obtaining of rs-(+/-)-2,3,5,6-tetrahydro-6-phenylimidazo-(2,1-b)-thiazol(tetramizol)
DE2827617A1 (de) * 1978-06-23 1980-01-10 Boehringer Sohn Ingelheim Neue imidazo eckige klammer auf 1,2- alpha eckige klammer zu imidazole, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
US4370500A (en) * 1978-11-06 1983-01-25 American Cyanamid Company Compound: d-N-(2-amino-2-phenethyl)-2-methoxyethylamine and process for preparing the same by selective crystallization
DE3042636A1 (de) * 1980-11-12 1982-06-16 C.H. Boehringer Sohn, 6507 Ingelheim Neue 7-(2,6-dibrom-4-methylphenyl)-2,3-dihydro-imidazo(1,2-a)imidazole, deren saeureadditionssalze, diese enhthaltende arzneimittel und verfahren zu deren herstellung
GB8509531D0 (en) * 1985-04-13 1985-05-15 Bp Chem Int Ltd Preparation of guanidines
US6359144B1 (en) * 1997-02-04 2002-03-19 Lion Bioscience Ag Combinatorial libraries of bicyclic guanidine derivatives and compounds therein
US6888004B2 (en) * 2001-01-26 2005-05-03 Bristol-Myers Squibb Company Imidazolyl derivatives as corticotropin releasing factor inhibitors
WO2003027115A1 (fr) * 2001-09-21 2003-04-03 Sanofi-Synthelabo Derives de 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidine-4-one et de 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidine-5(1h)one utilises pour le traitement de maladies neurodegeneratives
ATE482214T1 (de) * 2005-06-14 2010-10-15 Schering Corp Aspartylproteasehemmer
US8563560B2 (en) * 2011-02-25 2013-10-22 Ppg Industries Ohio, Inc. Preparation of bicyclic guanidine salts in an aqueous media

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB796996A (en) * 1956-03-29 1958-06-25 Monsanto Canada Ltd Imidazole derivatives
GB805877A (en) * 1957-01-28 1958-12-17 Monsanto Canada Ltd Process for the production of 2, 3, 5, 6-tetrahydro-1-imidaz (1, 2-a) imidazole

Also Published As

Publication number Publication date
RO63263A (fr) 1978-08-15
FR2209576A1 (fr) 1974-07-05
GB1446482A (en) 1976-08-18
BG21608A3 (fr) 1976-07-20
SE411627B (sv) 1980-01-21
DK141289B (da) 1980-02-18
FI54711B (fi) 1978-10-31
JPS4994694A (fr) 1974-09-09
FR2209576B1 (fr) 1977-01-28
DK141289C (fr) 1980-08-11
BE808416A (fr) 1974-06-10
SU578003A3 (ru) 1977-10-25
NO139087C (no) 1979-01-03
NL7316778A (fr) 1974-06-11
IL43770A0 (en) 1974-03-14
PH10417A (en) 1977-03-16
AU6337173A (en) 1975-06-12
ATA1026573A (de) 1976-04-15
NO139087B (no) 1978-09-25
HU168638B (fr) 1976-06-28
CA1010864A (en) 1977-05-24
US3865836A (en) 1975-02-11
DE2361188A1 (de) 1974-06-12
ZA739343B (en) 1975-07-30
PL94683B1 (pl) 1977-08-31
IE38618B1 (en) 1978-04-26
AT333770B (de) 1976-12-10
CH593975A5 (fr) 1977-12-30
FI54711C (fi) 1979-02-12
IE38618L (en) 1974-06-08

Similar Documents

Publication Publication Date Title
KR920701167A (ko) 약제학적 활성 화합물
CA2233285A1 (fr) Pyrazolopyrimidines en tant qu'antagonistes du recepteur de crf
PL335685A1 (en) Pyrrole[2,3-d]pyrimidines and their application as inhibitors of tyrosine kinase
HUT40798A (en) Process for producing new, heterocyclic imidazol derivatives and pharmaceutically acceptable acid additional salts thereof
IE882869L (en) Benzimidazoline-2-oxo-1-carboxylic acid derivatives
KR950005825A (ko) 4-아미노피리미딘 유도체
CA2278331A1 (fr) Derives de benzoyle substitues par 3-heterocyclyle
EP1156045A4 (fr) Derives d'amides et compositions de medicaments
CA2293621A1 (fr) 4-aminopyrrole(3,2-d)pyrimidines en tant qu'antagonistes du recepteur du neuropeptide y
HUP9901820A2 (hu) 4-Amino-pirimidin-származékok, ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk és eljárás előállításukra
WO2001014379A3 (fr) Nouvelle forme cristalline de disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-l- sel d'acide glutamique et procedes de preparation
HRP960155A2 (en) 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives
AU7581996A (en) 3-(4-subst.-piperidinyl-1)-1-(3,4-dichlorophenyl)propyl carbamates and ureas and derivatives as novel neurokinin antagonists
CA2376668A1 (fr) Derives de naphthyridine, procede de preparation, utilisation et compositions pharmaceutiques les renfermant
CA2084490A1 (fr) Procede pour la preparation de pyrrolo[2,3-d]pyrimidines
IE870128L (en) Dihydrobenzofuran and chroman - carboxamides
AU4629796A (en) 5-(4-subst.-piperidinyl-1)-3-aryl-pentanoic acid derivatives as tachykinin receptor antagonist
CA2196263A1 (fr) Methode de preparation de sels de 4-oxo-imidazolinium
CA2219359A1 (fr) Derives hydantoine utilises comme produits intermediaires pour principes actifs pharmaceutiques
WO2003028732A1 (fr) Antagoniste de recepteur
GB1446482A (en) Imidazo 1,2-a-imidazoles imidazo 1,2-a-pyrimidines and pyrimido 1,2-a-pyrimidines and methods for their preparation
UA72923C2 (uk) Заміщені похідні пурину як інгібітори клітинної адгезії
ATE267803T1 (de) Carbonsäureamide, deren herstellung und deren verwendung als arzneimittel
CA2278057A1 (fr) Antagonistes de tachykinine
CA2255530A1 (fr) Composition de couche barriere pour des corps en plastique